Trial Search Results

PRESERVE-Zenith® Iliac Branch System Clinical Study

The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the treatment of aorto-iliac and iliac aneurysms.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Cook Group Incorporated

Intervention(s):

  • Device: Endovascular repair for aortoiliac or iliac aneurysms.

Phase:

N/A

Eligibility


Inclusion Criteria:

   - An aortoiliac or iliac aneurysm of appropriate size

   - Unsuitable distal sealing site for a traditional Zenith® iliac leg graft within the
   common iliac artery

Exclusion Criteria:

   - Less than 18 years of age

   - Inability or refusal to give informed consent

   - Disease considerations that would compromise patient safety or study outcomes

   - Unsuitable arterial anatomy

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jason Lee
6507255227
Recruiting